ERBB2 and neoplasm: Young women have a higher incidence of tumors with poor prognostic features, including negative estrogen receptor (ER−) status, larger tumor size (> 2.0 cm), HER2 overexpression, epidermal growth factor receptor expression, lymph node involvement, and high nuclear grade.